Filing Details
- Accession Number:
- 0001567619-21-016263
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-08-24 11:50:54
- Reporting Period:
- 2021-08-19
- Accepted Time:
- 2021-08-24 11:50:54
- Original Submission Date:
- 2021-08-23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080014 | Innoviva Inc. | INVA | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1750085 | Marianne Zhen | 1350 Old Bayshore Highway, Suite 400 Burlingame CA 94010 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-08-20 | 1,129 | $15.89 | 35,364 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The Form 4 of the Reporting Person filed with the Securities and Exchange Commission on August 23, 2021 inadvertently indicated in Column 4 of Table I that the sale by the Reporting Person of 1,129 shares of Common Stock of the Issuer on August 20, 2021 was an acquisition "(A)" rather than a disposition "(D)". For the avoidance of doubt, such sale transaction was a disposition "(D)".